Light induced drug delivery into cancer cells.

Cell-penetrating peptides (CPPs) can be used for intracellular delivery of a broad variety of cargoes, including various nanoparticulate pharmaceutical carriers. However, the cationic nature of all CPP sequences, and thus lack of cell specificity, limits their in vivo use for drug delivery applications. Here, we have devised and tested a strategy for site-specific delivery of dyes and drugs into cancer cells by using polymers bearing a light activated caged CPP (cCPP). The positive charge of Lys residues on the minimum sequence of the CPP penetratin ((52)RRMKWKK(58)) was masked with photo-cleavable groups to minimize non-specific adsorption and cellular uptake. Once illuminated by UV light, these protecting groups were cleaved, the positively charged CPP regained its activity and facilitated rapid intracellular delivery of the polymer-dye or polymer-drug conjugates into cancer cells. We have found that a 10-min light illumination time was sufficient to enhance the penetration of the polymer-CPP conjugates bearing the proapoptotic peptide, (D)(KLAKLAK)(2), into 80% of the target cells, and to promote a 'switch' like cytotoxic activity resulting a shift from 100% to 10% in cell viability after 2 h. This report provides an example for tumor targeting by means of light activation of cell-penetrating peptides for intracellular drug delivery.

[1]  F. Kratz,et al.  Anticancer carrier-linked prodrugs in clinical trials , 2007, Expert opinion on investigational drugs.

[2]  Thommey P. Thomas,et al.  Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate. , 2010, Chemical communications.

[3]  A. David,et al.  E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells. , 2009, Biomaterials.

[4]  J. Mai,et al.  A proapoptotic peptide for the treatment of solid tumors. , 2001, Cancer research.

[5]  A. Surolia,et al.  Photoswitchable cluster glycosides as tools to probe carbohydrate-protein interactions: synthesis and lectin-binding studies of azobenzene containing multivalent sugar ligands. , 2005, Glycobiology.

[6]  David S Lawrence,et al.  Illuminating the chemistry of life: design, synthesis, and applications of "caged" and related photoresponsive compounds. , 2009, ACS chemical biology.

[7]  R. Fåhraeus,et al.  Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[8]  Measurement of nucleotide exchange rate constants in single rabbit soleus myofibrils during shortening and lengthening using a fluorescent ATP analog. , 2000, Biophysical journal.

[9]  T. Allen Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[10]  P. Neveu,et al.  Two-photon uncaging with the efficient 3,5-dibromo-2,4-dihydroxycinnamic caging group. , 2007, Angewandte Chemie.

[11]  J. Kopeček,et al.  Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[12]  B. Imperiali,et al.  Chemical approaches for investigating phosphorylation in signal transduction networks. , 2005, Trends in cell biology.

[13]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[14]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[15]  S. Bishop,et al.  De novo antimicrobial peptides with low mammalian cell toxicity. , 1996, Journal of medicinal chemistry.

[16]  W Todd Monroe,et al.  Photobiological and thermal effects of photoactivating UVA light doses on cell cultures , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[17]  Brian P. Timko,et al.  Photo-targeted nanoparticles. , 2010, Nano letters.

[18]  M. Metsis,et al.  Cell Penetrating Peptides , 2000 .

[19]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[20]  K. Ulbrich,et al.  Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[21]  A. David,et al.  Multivalent display of quinic acid based ligands for targeting E-selectin expressing cells. , 2009, Journal of medicinal chemistry.

[22]  N. Ohgami,et al.  Synthesis and biochemical properties of a new photoactivatable cholesterol analog 7,7-azocholestanol and its linoleate ester in Chinese hamster ovary cell lines DOI 10.1194/jlr.M200015-JLR200 , 2002, Journal of Lipid Research.

[23]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. B. Merrifield,et al.  Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. , 1981, Analytical biochemistry.

[25]  Cha-Min Tang,et al.  N-Nmoc-l-Glutamate, a New Caged Glutamate with High Chemical Stability and Low Pre-photolysis Activity* , 1997, The Journal of Biological Chemistry.

[26]  Vladimir P Torchilin,et al.  Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.

[27]  S. Schwarze,et al.  In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. , 2000, Trends in pharmacological sciences.

[28]  K. Ulbrich,et al.  New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Roger Y Tsien,et al.  In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[30]  Z. Lu,et al.  HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  G. Ashkenasy,et al.  Light-induced peptide replication controls logic operations in small networks. , 2010, Chemistry.

[32]  R. Satchi‐Fainaro,et al.  Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate. , 2009, Angewandte Chemie.

[33]  M. Pincus,et al.  PNC‐28, a p53‐derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo , 2006, International journal of cancer.

[34]  Hazel A. Collins,et al.  Two-photon absorption and the design of two-photon dyes. , 2009, Angewandte Chemie.

[35]  R. Tsien,et al.  Caged nitric oxide. Stable organic molecules from which nitric oxide can be photoreleased. , 1994, The Journal of biological chemistry.

[36]  Günter Mayer,et al.  Biologically active molecules with a "light switch". , 2006, Angewandte Chemie.

[37]  V. Torchilin,et al.  Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates. , 2007, Bioconjugate chemistry.

[38]  J. Goedhart,et al.  Photolysis of caged phosphatidic acid induces flagellar excision in Chlamydomonas. , 2004, Biochemistry.

[39]  I. Hamachi,et al.  Caged RNase: photoactivation of the enzyme from perfect off-state by site-specific incorporation of 2-nitrobenzyl moiety. , 2003, Bioorganic & medicinal chemistry letters.

[40]  V. Saudek,et al.  ENZYMATIC CLEAVAGE OF SIDE CHAINS OF SYNTHETIC WATER-SOLUBLE POLYMERS. , 1976 .

[41]  J. Kopeček,et al.  Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization , 1973 .

[42]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[43]  R. Weissleder,et al.  A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity , 2006, Molecular Cancer Therapeutics.

[44]  Vincent M Rotello,et al.  Photoregulated release of caged anticancer drugs from gold nanoparticles. , 2009, Journal of the American Chemical Society.

[45]  You Han Bae,et al.  TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[46]  London Wc,et al.  De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity , 1996 .

[47]  Ehud Segal,et al.  Design and development of polymer conjugates as anti-angiogenic agents. , 2009, Advanced drug delivery reviews.